POLYRIZON

polyrizon-logo

Polyrizon is a domain name services firm expertise in domain consulting and boutique domain brokerage services.

#SimilarOrganizations #People #Website #More

POLYRIZON

Social Links:

Industry:
Biotechnology

Address:
Ra'anana, HaMerkaz, Israel

Country:
Israel

Website Url:
http://www.polyrizon-biotech.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API WordPress Google Maps LetsEncrypt SSL By Default Font Awesome


Similar Organizations

albero-logo

albero

albero is a company that expertise in domain registration, web construction and CMS services.

domain-cocoon-logo

Domain Cocoon

Domain Cocoon helps to protect and grow domain names and provides custom registrar solutions, consultation and management services.

yash-infosolutions-logo

Yash Infosolutions

Yash Infosolutions is an IT company that provides domain registration, web design, security management, consultation, and cloud services.

Current Employees Featured

not_available_image

Eyal S. Ron
Eyal S. Ron Chief Technology Officer @ Polyrizon
Chief Technology Officer
2020-03-01

Official Site Inspections

http://www.polyrizon-biotech.com

  • Host name: 699050.cloudwaysapps.com
  • IP address: 46.101.45.46
  • Location: London United Kingdom
  • Latitude: 51.5353
  • Longitude: -0.6658
  • Timezone: Europe/London
  • Postal: SL1

Loading ...

More informations about "Polyrizon"

PLRZ - Overview

Polyrizon Ltd. Company Overview We are a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, โ€ฆSee details»

PLRZ - Governance - investor.polyrizon-biotech.com

Audit Committee Compensation Committee Nominating and Corporate Governance Committee Mr. Asaf Itzhaik Yehonatan Zalman VinokurSee details»

PLRZ - Management - investor.polyrizon-biotech.com

Dr. Tidhar Turgeman has served as our Chief R&D Officer since December 2020. Prior to that, Mr. Turgeman served as an Innovative drug delivery technologies products development โ€ฆSee details»

Polyrizon Company Profile - Office Locations, Competitors, โ€ฆ

Polyrizon has 1 employees at their 1 location. See insights on Polyrizon including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. ... Polyrizon is a โ€ฆSee details»

Polyrizon Enters into GMP Manufacturing Agreement for CTM โ€ฆ

Raanana, Israel, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of โ€ฆSee details»

Polyrizon - CAPTURE & CONTAIN

The Capture and Contain Platform (C&Cโ„ข) is based on natural 3-D polymeric network tailored to optimally adhere to the nasal mucosal surface. The polymeric network creates a physical barrier that Captures and Contains biological โ€ฆSee details»

Polyrizon - Expanding horizons of intranasal care - polyrizon โ€ฆ

Polyrizon is a biotech company, focused on the development and commercialization of innovative intranasal products based on the Companyโ€™s technology platforms.See details»

Polyrizon Enters into GMP Manufacturing Agreement for CTM

Dec 3, 2024 Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin โ€ฆSee details»

Polyrizon Ltd. Company Research Report - askcyborg.com

Polyrizon Ltd. is a trailblazing company at the forefront of biotechnology, specializing in the development of innovative solutions to protect againstSee details»

PLRZ - Board of Directors - investor.polyrizon-biotech.com

Prior to that, between 2021 to 2024, Mr. Srugo was a Senior Financial Advisor at Somekh Chaikin, a member firm of KPMG, where he led teams in financial due diligence and โ€ฆSee details»

PLRZ Stock Price Quote - Morningstar

Dec 5, 2024 Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross โ€ฆSee details»

Polyrizon Teams Up With Eurofins To Secure Clinical Trial ... - Nasdaq

Dec 2, 2024 (RTTNews) - Polyrizon Ltd. (PLRZ), a biotech company, announced today that it has entered into a manufacturing agreement with Eurofins Contract Development & โ€ฆSee details»

Polyrizon Enters into GMP Manufacturing Agreement for CTM โ€ฆ

Dec 2, 2024 Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the โ€ฆSee details»

Trap & Target - Polyrizon-Biotech

Providing new horizon for Intranasal drugs delivery. The T&T platform delivery technology is designed to allow a long residence time and an intimate contact with the mucosal tissue for a โ€ฆSee details»

Polyrizon pays $3M for license to SciSparc's CB2R agonist - Fierce โ€ฆ

Aug 19, 2024 Israeli biotech SciSparc has sold the license for its cannabinoid receptor type 2 (CB2R) agonist to its partner Polyrizon to further develop as a pain therapy.. The agreement โ€ฆSee details»

PLRZ - Stock Info - investor.polyrizon-biotech.com

Nov 19, 2024 Date Price Open Prev CloseSee details»

Polyrizon Stock Price | PLRZ Stock Quote, News, and History

Nov 3, 2024 On Tuesday morning 12/10/2024 the Polyrizon Ltd Registered Shs share started trading at the price of $1.07. Compared to the closing price on Monday 12/09/2024 on BTT of โ€ฆSee details»

Polyrizon (PLRZ) Stock Price, News & Analysis - MarketBeat

3 days ago Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. โ€ฆSee details»

Polyrizon Enters into GMP Manufacturing Agreement for CTM

Dec 2, 2024 Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin โ€ฆSee details»

Polyrizon - Press release - polyrizon-biotech.com

Press Release July 2022 Polyrizon Signed an Agreement with Nurexone for Intranasal Administration of Cutting - Edge Therapy for Spinal Cord Injuries Link July 2022 May 2022 โ€ฆSee details»

linkstock.net © 2022. All rights reserved